Skip to content
WE ARE HIRING
Verify Insurance
Our Programs
Medical Detox
Inpatient Residential Rehab
Partial Hospitalization Program
Intensive Outpatient Program
Outpatient Treatment
Treatment
Alcohol Abuse Treatment
Drug Addiction Treatment
Behavioral and Mental Health
About
Admissions
Arizona Rehab Campus
Amenities at Arizona Rehab Campus
Who We Are
Testimonials
Careers
Frequently Asked Questions
Our Podcast
Resources
Addiction
Guides
Recovery
Insurance
Contact Us
Verify Insurance
Our Programs
Medical Detox
Inpatient Residential Rehab
Partial Hospitalization Program
Intensive Outpatient Program
Outpatient Treatment
Treatment
Alcohol Abuse Treatment
Drug Addiction Treatment
Behavioral and Mental Health
About
Admissions
Arizona Rehab Campus
Amenities at Arizona Rehab Campus
Who We Are
Testimonials
Careers
Frequently Asked Questions
Our Podcast
Resources
Addiction
Guides
Recovery
Insurance
Contact Us
We're Available 24/7
520-526-1000
Addiction & Substance Abuse Glossary
Jump to Section:
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
#
12-Step Program
A
Abstinence
Abuse
Acetaminophens
Addict
Addiction
Addiction Assessment
Adverse Reaction
Affinity
Age at Onset
Agonist
Alcoholics Anonymous (AA)
Alkaloids
Amphetamine
Analgesic
Antagonist
AOD
AODA
Aspirin
Assessment
Average Length of Stay
Axon
B
Barbiturate
Benzodiazepine
Binge Drinking
Bioavailability
Biofeedback
Biopsychosocial
Boundary
Buprenorphine
C
Caffeine
Carcinogen
Case Management
Causal Factors
Ceiling Effect
Chronic
Cirrhosis
Clinical Decision Support
Clinical Opiate Withdrawal Scale (COWS)
Clinical Trial
Co-Occurring
Cocaine
Codeine
Codependency
Cognitive-Behavioral Therapy (CBT)
Cold Turkey
Compulsion
Compulsivity
Continuum of Care
Cost-Benefit Study
Cost-Effectiveness Study
Crisis Intervention
Cross-Tolerance
D
Denial
Dependence
Depressants
Depression
Discharge
Disease
Disease Model
Dissemination
Doctor-shopping
Dopamine
Driving under the Influence (DUI)
Drug Diversion
Drug Enforcement Administration (D.E.A.)
Drug Misuse
Drug of Choice (D.O.C)
Drug Tolerance
DSM
DWI
Dysphoria
E
Ecstasy (MDMA)
Enabling
Endogenous Opioid
Endorphins
Ethanol
Euphoria
Evidence-based Treatment (EBT)
Excipient
F
Fentanyl
Fetal Alcohol Spectrum Disorders (FASD)
Fetal Alcohol Syndrome (FAS)
Fidelity
Food and Drug Administration (FDA)
G
GHB (Gamma-hydroxybutyrate)
H
Habit
Hallucinations
Hallucinogen
Harm Reduction
Health Care System
Health Disparities
Heavy Drinking
Heroin
HIPAA
Hydrocodone
Hydromorphone
I
Implementation
Impulsivity
Inhalants
Inpatient Treatment
Integration
Intervention
Intoxication
Intranasal
K
Ketamine
Kratom
L
Learning Health Care System
Legal Drugs
Levels of Care (LOC)
Limbic System
Longitudinal Study
LSD
M
Maintenance
Maintenance Medications
Marijuana
Meaningful Use
Medicated Assisted Treatment (MAT)
Meperidine
Mescaline or Peyote
Metabolism (of drugs)
Methadone
Methamphetamine
Methylphenidate
Monotherapy
Morphine
Mushrooms or Psilocybin
N
Naloxone
Naltrexone
Narcan
Narcotic
Narcotics Anonymous (NA)
National Board of Addiction Examiners (NBAE)
Negative Reinforcement
Net Economic Benefit
Neurobiology
Neurotransmitter
Nicotine
Nitrous Oxide
Nonopioid
O
Obsession
Off-Label Use
Opiate
Opioid Treatment Program (OTP)
Opioids
Opium
Outpatient Treatment
Over-the-Counter Drugs
Oxycodone
Oxymorphone
P
Painkillers
Partial Agonists
Peer Support
Pharmacokinetics
Pharmacology
Phencyclidine (PCP)
Physical Dependence
Pink Cloud
Placebo
Polysubstance Abuse
Positive Reinforcement
Post-Acute Withdrawal Syndrome (PAWS)
Pre-Existing Condition
Precipitated Withdrawal Syndrome
Prescription Drug Misuse
Prescription Drugs
Prevalence
Prior Authorization
Protective Factors
Psychedelic Drugs
Psychoactive Drug
Psychoanalysis
Psychological Dependence
Psychopharmacology
Psychotropic Drug
Public Health System
Q
Quality-Adjusted Life Year (QALY)